Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part in a clinical study and are able to follow and complete all study procedures
- People aged between 18 and 80 years old at the time of signing the consent form (including those who are exactly 18 or 80)
- People with a good general health and activity level, rated as fully active or able to carry out light work (ECOG score of 0 or 1)
- People who have not previously had surgery for lung cancer
- People whose lung cancer type has been confirmed during or after surgery as non-small cell lung cancer
- People who have a single lung nodule that appears as a mix of solid and hazy (ground glass) areas on a CT scan, or multiple nodules where the main nodule matches this description
- People whose nodule has a solid portion making up between 50% and 100% of the nodule, and where the total nodule size is 2 cm or smaller
- People whose cancer is at an early stage (T1N0M0) and where surgery to fully remove the cancer is considered possible
- People who have not yet received any radiotherapy or chemotherapy as an initial treatment
Who may not be able to join:
- People whose cancer does not meet the specific early-stage criteria of a solid portion between 50% and 100% with a diameter of 2 cm or less (confirm with trial site)
- People for whom complete surgical removal of the cancer is not possible
- People whose cancer has been confirmed by tissue or cell testing to be a type of lung cancer other than non-small cell lung cancer
- People who have previously had surgery for lung cancer
- People who have already received radiotherapy or chemotherapy, where that treatment was not the first (primary) treatment given
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Haiquan Chen, Fudan University
Phone: +86-13278979834
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2-year disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.